[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100558013":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":18,"locations":24,"responsibleParty":40,"collaborators":10,"id":42,"slug":43,"hasResults":44,"nctId":45,"briefTitle":46,"officialTitle":47,"acronym":10,"eligibilityCriteria":48,"healthyVolunteers":44,"sex":49,"minAge":50,"maxAge":10,"enrollmentInfo":51,"targetDuration":10,"studyType":54,"phases":10,"briefSummary":55,"conditions":56,"keywords":58,"overallStatus":27,"whyStopped":10,"lastUpdateSubmitDate":62,"lastUpdatePostDateStruct":63,"startDateStruct":66,"completionDateStruct":68,"leadSponsor":70,"locationsCount":71},{"fullName":5,"class":6},"The Affiliated Hospital of Xuzhou Medical University","OTHER",[8,12,15],{"label":9,"type":10,"description":11,"interventionNames":10},"EVT-stroke group",null,"Patients with ischemic stroke who received endovascular thrombectomy (EVT) treatment",{"label":13,"type":10,"description":14,"interventionNames":10},"non--EVT stroke group","The non--EVT stroke group was composed of patients with ischemic stroke without endovascular thrombectomy (EVT) treatment during the same period",{"label":16,"type":10,"description":17,"interventionNames":10},"non--stroke control group","The non--stroke control group was composed of randomly selected stroke--free, age--matched and sex--matched individuals recruited from the health examination center.",[19],{"name":20,"role":21,"phone":22,"phoneExt":10,"email":23},"Xingzhi Wang, MD","CONTACT","0086-13852000759","wxz1220@126.com",[25],{"facility":26,"status":27,"city":28,"state":29,"zip":10,"country":30,"countryCode":31,"cosmosGeoPoint":32,"geoPoint":37,"contacts":38},"Department of Neurology","RECRUITING","Xuzhou","Jiangsu","China","CN",{"type":33,"coordinates":34},"Point",[35,36],117.28386,34.20442,{"lat":36,"lon":35},[39],{"name":20,"role":21,"phone":22,"phoneExt":10,"email":23},{"type":41,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100558013","predictive-role-of-strem-in-endovascular-thrombectomy-outcomes-100558013",false,"NCT06545591","Predictive Role of sTREM in Endovascular Thrombectomy Outcomes","Soluble Soluble Triggering Receptors Expressed on Myeloid Cells (sTREM) Predict Outcomes in Stroke Patients Receiving Endovascular Thrombectomy","Inclusion Criteria:\n\n* Patients \\> 18 years old.\n* Patients with acute large vessel occlusion within 24 hours of onset who will receive endovascular treatment.\n\nExclusion Criteria:\n\n* Impossibility of getting a blood sample.\n* Impossibility of performing the test (Invalid results).\n* Refusal to provide the informed consent by the patient\u002Frelative.","ALL","18 Years",{"count":52,"type":53},300,"ESTIMATED","OBSERVATIONAL","Soluble triggering receptor expressed on myeloid cells (sTREM), which reflects microglia activation, has been reported closely associated with neuronal injury and neuroinflammation. This study is to investigatethe prognostic roles of sTREM (sTREM1 and sTREM2) in patients with ischemic stroke who underwent endovascular thrombectomy (EVT).",[57],"Acute Ischemic Stroke",[59,60,61],"Thrombectomy","soluble TREM-1","soluble TREM-2","2024-08-07",{"date":64,"type":65},"2024-08-09","ACTUAL",{"date":67,"type":65},"2024-07-01",{"date":69,"type":53},"2027-12-31",{"name":5,"class":6},1]